Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1127749

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: BioMarin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the progress of talks on procuring medicines between the NHS and Bio Marin.
tabling member constituency	Gloucester
tabling member printed	Richard Graham
uin	256971
answer	answer is ministerial correction date of answer 30/05/2019 answer text <p>We have made no such assessment. Discussions about commercial agreements for medicines are rightly held between NHS England as an independent body and the manufacturer concerned. The Department plays no role in such discussions.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 30/05/2019 10:48:36 answering member 4455 label Biography information for Seema Kennedy
tabling member	3990 label Biography information for Richard Graham

1127772

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the review of the methods for the NICE Technology Appraisal Programme referred to in the 2019 voluntary scheme for branded medicines pricing and access will include support for earlier patient access to innovative medicines.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	257056
answer	answer is ministerial correction date of answer 30/05/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is in the process of scoping the review of the methods for technology appraisal and highly specialised technologies evaluations. Scoping will involve patient organisations and other relevant stakeholders, including industry. The Voluntary Scheme for Branded Medicines Pricing and Access sets out the Department’s expectation that that any future changes to NICE methods and processes would support faster adoption of the most clinically and cost effective medicines. Additional detail and more information will be made available on the NICE website in due course.</p><p>The 2019 Voluntary Scheme also states that NICE will adopt the principle of appraisal timelines for non-oncology treatments matching the faster timescales for oncology treatments, subject to the evidence base for the product being sufficiently developed to enable a NICE appraisal with the same level of rigour and certainty as would be expected currently.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 30/05/2019 10:52:06 answering member 4455 label Biography information for Seema Kennedy
tabling member	4398 label Biography information for Chris Green

1127886

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the oral contribution of the Prime Minister of 27 March 2019, Official Report column 321, when funding for the General Practice work stream of the NHS Getting it Right First Time programme will be in place; and when an announcement will be made on the (a) commencement date and (b) timeframe for that work stream.
tabling member constituency	Romford
tabling member printed	Andrew Rosindell
uin	257008
answer	answer is ministerial correction date of answer 30/05/2019 answer text <p>The Getting It Right First Time (GIRFT) programme aims to drive improvements in medical and surgical specialties through clinical leadership and the use of data to identify and reduce unwarranted variation in practice. By tackling variations in the way services are delivered across the National Health Service, and by sharing best practice between trusts, GIRFT identifies changes that will help improve care and patient outcomes, as well as delivering efficiencies such as the reduction of unnecessary procedures and cost savings.</p><p>The GIRFT programme has recently concluded a pilot looking at applying the GIRFT methodology in primary care. The Department, NHS England and NHS Improvement are reviewing the findings of the pilot and will agree the appropriate next steps in the context of the new GP contract and Primary Care Networks currently being established which have an associated improvement support programme.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 30/05/2019 10:29:12 answering member 1585 label Biography information for Stephen Hammond
tabling member	1447 label Biography information for Andrew Rosindell

1127949

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	5G: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what studies have been carried out to evaluate the effect of 5G on (a) pregnant women, (b) babies and (c) young children.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	256920
answer	answer is ministerial correction date of answer 30/05/2019 answer text <p>A considerable amount of research has been carried out on exposure to radio waves over several decades, and evidence reviews have been prepared by scientific expert groups in the United Kingdom and around the world. Among the health topics investigated is whether adverse effects can occur in relation to reproduction and development.</p><p>Public Health England (PHE) has published a webpage about exposure to the radio waves from mobile phone base stations, including those for 5G networks, at the following link:</p><p><a href="https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health" target="_blank">https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health</a></p><p>Based on the accumulated evidence and reviews, PHE advises that the guidelines of the International Commission on Non-Ionizing Radiation Protection (ICNIRP) should be adopted and there is no convincing evidence that radio wave exposures below the ICNIRP guideline levels cause adverse health effects. This includes effects in relation to reproduction and development.</p><p>PHE has committed to keeping the emerging evidence under review and to preparing another comprehensive review when sufficient new evidence has accumulated.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 30/05/2019 10:39:58 answering member 4455 label Biography information for Seema Kennedy
tabling member	252 label Biography information for Dr David Drew